Tag: Amicus Therapeutics

This deal puts Amicus in a better position to increase its revenues and become a leading biotech in the field of rare diseases. Blackstone only requires interest-only payments until late 2026, with a maturity date of October 2029. Apart from debt refinancing, the money will also go towards continued operations. The President and Chief Executive…